| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/13/2000 | WO2000001375A2 Calcium channel blockers |
| 01/13/2000 | WO2000001349A2 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 01/13/2000 | WO1999059617A3 Immunoregulator |
| 01/13/2000 | WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/13/2000 | WO1999050252A3 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
| 01/13/2000 | DE19830649A1 Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe The topical patch with NSAIDs with acid group |
| 01/13/2000 | CA2336709A1 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/13/2000 | CA2336406A1 Galectin 11 |
| 01/13/2000 | CA2336134A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | CA2335920A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/13/2000 | CA2331394A1 Human emr1-like g protein coupled receptor |
| 01/12/2000 | EP0970950A2 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/12/2000 | EP0970949A1 Acridine derivatives |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970109A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970108A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970082A2 Biazacyclic crf antagonists |
| 01/12/2000 | EP0970081A1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders |
| 01/12/2000 | EP0970067A1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors |
| 01/12/2000 | EP0970060A1 Lta 4 hydrolase inhibitors |
| 01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/12/2000 | EP0969836A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/12/2000 | EP0969817A1 Dosage forms having improved release properties |
| 01/12/2000 | EP0941224A4 Multivalent salts of pyridostigmine and related compounds |
| 01/12/2000 | EP0862566B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 01/12/2000 | CN1241185A Heterocyclic substed. pyrrolidine amide derivs. |
| 01/12/2000 | CN1241178A Novel compounds with analgesic effect |
| 01/12/2000 | CN1241177A Substed. 4-biphenyl-4-hydroxybutyric acid derivs. as matrix metalloprotease inhibitors |
| 01/12/2000 | CN1240788A Acridine derivatives |
| 01/12/2000 | CN1240658A Quickly-acting antalgesic liniment and its preparing process |
| 01/12/2000 | CN1240648A Transition metal complexes of non steroidal anti-inflammatory drugs |
| 01/12/2000 | CN1240646A Injectable composition of non-steroidal anti-inflammatory drugs |
| 01/12/2000 | CN1048241C Vitamin D analogues, their preparing process, pharmaceutical composition contg. same and use thereof |
| 01/11/2000 | US6013814 Vitamin D analogues |
| 01/11/2000 | US6013792 Matrix metalloprotease inhibitors |
| 01/11/2000 | US6013674 Indenone amide derivatives, useful for for the inhibition of leukocyte adherence to endothelial cells; useful in the treatment of inflammatory diseases, as arthritis, asthama, psoriasis, respiratory distress syndrome, stroke and ulcer |
| 01/11/2000 | US6013670 Administering c1-c6 alkanoyl carnitine or salt to treat chronic inflammatory bowel disease |
| 01/11/2000 | US6013648 Immunomodulators |
| 01/11/2000 | US6013627 Organic compounds |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013479 Human Emr1-like G protein coupled receptor |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013464 Human PAK65 |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | US6013450 CAF1-related protein |
| 01/11/2000 | US6013244 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them |
| 01/11/2000 | US6012375 Aircraft infrared guided defense missile system |
| 01/11/2000 | CA2180754C Heteroaryl-substituted deoxy glycero-phosphoethanolamines |
| 01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
| 01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
| 01/06/2000 | WO2000000596A1 3'-exonuclease, production and use thereof |
| 01/06/2000 | WO2000000594A2 Human transferases |
| 01/06/2000 | WO2000000587A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | WO2000000473A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 01/06/2000 | WO2000000465A1 Hydrazine derivatives |
| 01/06/2000 | WO2000000209A2 Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions |
| 01/06/2000 | WO2000000201A1 BICYCLIC sPLA2 INHIBITORS |
| 01/06/2000 | WO2000000200A1 A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR |
| 01/06/2000 | WO1999051185A3 Human galactosyl transferases |
| 01/06/2000 | CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | CA2335921A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 01/06/2000 | CA2335516A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | CA2335448A1 Bicyclic spla2 inhibitors |
| 01/06/2000 | CA2335245A1 Hydrazine derivatives |
| 01/06/2000 | CA2334515A1 A pharmaceutical combination comprising a cox-2 inhibitor and a inos inhibitor |
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
| 01/06/2000 | CA2330565A1 Growth factor modulators |
| 01/06/2000 | CA2330525A1 Human transferases |
| 01/05/2000 | EP0968718A1 Remedies for ulcerative colitis |
| 01/05/2000 | EP0968304A1 Identification of inhibitors of protein tyrosine kinase 2 |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968226A1 G-rich oligo aptamers and methods of modulating an immune response |
| 01/05/2000 | EP0968206A1 N-heterocyclic derivatives as nos inhibitors |
| 01/05/2000 | EP0968182A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/05/2000 | EP0968180A1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii |
| 01/05/2000 | EP0967996A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 01/05/2000 | EP0967978A2 Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol |
| 01/05/2000 | EP0967976A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 01/05/2000 | CN1240438A Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them |
| 01/05/2000 | CN1240357A Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 01/05/2000 | CN1240146A Medicine for treating skin ringworm and dermatitis and preparation process |
| 01/05/2000 | CN1240142A Compound longshou soluble granules |
| 01/05/2000 | CN1240132A Controlled release formulation |
| 01/05/2000 | CN1048014C Substituted pyrroles compound and preparational process, medicinal compositions and use |
| 01/04/2000 | US6011159 Processes and intermediates for preparing substituted indazole derivatives |
| 01/04/2000 | US6011138 Gamma-1 anti-human CD23 monoclonal antibodies |
| 01/04/2000 | US6011136 Inhibitor of tumor necrosis factor; antiinflammatory agents |
| 01/04/2000 | US6011060 Treating a disease mediated by activation of the tumor necrosis factor |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
| 01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
| 01/04/2000 | US6011037 Thiazole derivatives with phosphodiesterase-inhibiting action |
| 01/04/2000 | US6011035 Libraries of these compounds can also be used to identify antagonists for other targets. compounds containing benzhydril and 6-membered heterocyclic moieties |
| 01/04/2000 | US6011028 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 01/04/2000 | US6010483 Patient controlled analgesia device for use with ultrashort acting opioid medication and method for using the same |